BioCentury
ARTICLE | Clinical News

Neutralase heparinase I enzyme: Phase II

July 22, 1996 7:00 AM UTC

Ibex Technologies Inc. (TSE:IBT), Montreal, Quebec Product: Neutralase heparinase I enzyme Indication: Heparin reversal after cardiac bypass surgery Status: IBT began Phase II testing of safety and ef...